Evidence policy

Evidence should remain attached to the person, source and permission behind it.

Evidence is classified before it is published. First-party facts appear directly; third-party platform displays appear only with attribution, retrieval date and limitations; sales results, transaction counts, client stories and quotations remain excluded until they are verified and approved for reuse.

01

Paul evidence is not team evidence

Elevate Realty Group maintains a testimonials page and third-party platforms display profiles associated with Paul. Team reviews cannot be presented as Paul’s individual reviews. Dynamic third-party totals may be documented on the professional-record page with the platform, retrieval date and sample limitation, but are not hardcoded into rating schema or promoted as owned proof.

When approved evidence is added, the record should preserve the exact quotation, reviewer attribution permitted for publication, source, date, transaction context if known and permission status. Quotes are not rewritten into stronger claims.

02

Process evidence at launch

In the absence of approved client evidence, this site relies on documented biography, source-linked organizational history and a transparent representation process. It states what is known, labels service elements as subject to the agreed plan and avoids outcome guarantees.

That is intentionally less dramatic than fabricated proof. It gives a prospective client a basis for a real conversation and gives the site owner a clean structure for adding evidence responsibly later.

03

Future case studies

A useful case study can describe property type, general community, challenge, positioning, marketing or search strategy, timeline, outcome and lessons without revealing confidential details. The client and property must not be identifiable unless publication is authorized.

Results also need context. A sale price alone does not prove strategy; a timeline alone does not show the conditions. Future case studies should explain the decision and the work, separate Paul’s role from the team’s role and avoid implying that one outcome predicts another.

04

What remains awaiting confirmation

Current exclusions include Paul-specific luxury sales totals, transaction counts, market share, independently conferred brokerage awards, verified case outcomes and any current Real mentor role. No qualifying first-party source was located for those claims. Dynamic third-party profile evidence is attributed and date-stamped rather than promoted as owned proof.

The source ledger separately records verified first-party facts, historical team facts and attributed third-party profile displays. The record can be updated when Paul supplies transaction documentation, approved case studies or client permissions.

05

Decision frame: publishing client and performance evidence

Evidence belongs to the person, team, period and transaction it actually describes. A team testimonial is not automatically Paul’s testimonial, a platform recommendation count is not a sales count and an active listing is not a closed outcome.

Define the decision in writing before tactics begin. Record the people affected, the property or relationship in scope, timing constraints, information already known and the decision that must be made next. For publishing client and performance evidence, a useful brief also states what a successful process must protect—not just the hoped-for result.

06

The evidence file

A publishable client record should preserve the exact approved quotation, permitted attribution, original source, date, scope of Paul’s role, property context appropriate for disclosure and proof of permission. Production evidence should identify the brokerage source, period, metric definition and whether it is individual or team.

Separate source documents from summaries and interpretation. Note who produced each item, what date or period it covers, whether it describes Paul, Elevate, the brokerage, the property or a third party, and what remains uncertain. That makes later recommendations traceable and prevents a convenient number from carrying more weight than its source allows.

07

Trade-offs worth naming early

Rewritten quotes, borrowed team totals, cherry-picked outcomes and stale platform counts can mislead even when the underlying material exists. Privacy may also make a strong case unsuitable for public use. Rating schema should not be added merely because a third-party page displays a score.

A sophisticated plan rarely removes every risk. It identifies which uncertainty can be investigated, which can be managed through terms or sequencing, which may be reflected in price and which should remain a reason to pause. Naming those categories early reduces the chance that urgency, presentation or sunk cost quietly changes the client’s standard.

08

A working sequence

Collect source material, classify scope, verify with the appropriate first party, obtain permission, redact private details, draft restrained copy, review the final context and add schema only when every visible and structured claim is supported.

Each stage should end with a visible decision: proceed, revise the brief, request a specialist, change the timing or stop. Responsibilities and approvals should be explicit. The sequence may compress when circumstances require it, but compression should be acknowledged so the client understands which work has been completed and which uncertainty remains.

09

Questions for the first conversation

A considered first conversation is more useful when the unresolved questions are visible. The purpose is not to force an immediate commitment; it is to determine whether the advisor’s method, scope and evidence standard fit the decision.

  • Whose result or experience is this?
  • What exact period and metric are involved?
  • Is publication permission documented?
  • Could the context identify a private client or property?
  • Does the visible copy match any structured data exactly?

Next step

Evaluate fit through a conversation.

Ask Paul how he would frame your property or search and what evidence would guide the recommendation.

Speak with Paul’s team
Call Paul · 780 217 1114